These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31196027)

  • 1. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
    Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
    BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDCA2 triggers in vivo and in vitro proliferation of hepatocellular carcinoma by activating the AKT/CCND1 signaling.
    Li J; Chen Y; Wang X; Wang C
    J BUON; 2021; 26(3):882-888. PubMed ID: 34268949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F3/CDCA2 reduces radiosensitivity in gastric adenocarcinoma by activating PI3K/AKT pathway.
    Gao J; Wang H; Qiu X; Tang J
    Br J Radiol; 2023 Dec; 96(1152):20230477. PubMed ID: 37750838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway.
    Li K; Fan T; Shi Z; Jiang H
    Anal Cell Pathol (Amst); 2022; 2022():9912254. PubMed ID: 36588796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
    Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
    Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
    Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
    Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.
    Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z
    J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner.
    Wang J; Liu X; Chu H; Chen J
    PeerJ; 2022; 10():e13535. PubMed ID: 35694386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells.
    Watanabe T; Semba S; Yokozaki H
    Br J Cancer; 2011 Jan; 104(1):146-54. PubMed ID: 21102582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo.
    Qin AC; Li Y; Zhou LN; Xing CG; Lu XS
    Cell Physiol Biochem; 2019; 52(4):758-768. PubMed ID: 30933440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
    Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
    Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
    PLoS One; 2013; 8(2):e56381. PubMed ID: 23418564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
    Zhang Y; Wang S; Qian W; Ji D; Wang Q; Zhang Z; Wang S; Ji B; Fu Z; Sun Y
    Oncol Rep; 2018 Aug; 40(2):1119-1128. PubMed ID: 29901203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
    Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
    Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.
    Chen Y; Jiang J; Zhao M; Luo X; Liang Z; Zhen Y; Fu Q; Deng X; Lin X; Li L; Luo R; Liu Z; Fang W
    Oncotarget; 2016 Jul; 7(27):41306-41319. PubMed ID: 27191497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.
    Gu Y; Li A; Sun H; Li X; Zha H; Zhao J; Xie J; Zeng Z; Zhou L
    Int J Mol Med; 2018 May; 41(5):2660-2668. PubMed ID: 29393377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway.
    Xiang L; Xie G; Ou J; Wei X; Pan F; Liang H
    PLoS One; 2012; 7(4):e35378. PubMed ID: 22496919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.